• DDM for Membrane Protein Assays: A Decision Framework

  2026-08-22

  DDM is more than a membrane protein solubilizer: it can shape purification yield, structural integrity, and assay interpretation. This guide uses WecA research to show how to deploy n-Dodecyl-β-D-maltoside rationally.

• Aprotinin for Protease-Controlled GRO-seq Workflows

  2026-08-21

  Aprotinin adds a controlled serine-protease inhibition step to workflows that preserve nuclei, protein complexes, and nascent-transcription readouts. This article connects BPTI-enabled protease studies with the reference GRO-seq innovation: rRNA depletion before nascent-RNA immunoprecipitation.

• Capsaicin Workflows for TRPV1 and KDM1A

  2026-08-20

  Capsaicin is a versatile research tool that connects rapid TRPV1 ion channel activation with slower KDM1A/LSD1-dependent transcriptional effects. This guide translates those properties into practical workflows for sensory-neuron assays, pain and inflammation models, and gastric cancer studies, with concentration planning and troubleshooting built in.

• Palonosetron Hydrochloride in CINV Prevention

  2026-08-20

  The reference paper presents palonosetron as a pharmacologically distinctive 5-HT3 receptor antagonist whose long half-life, high receptor affinity, allosteric binding, and positive cooperativity may improve control of delayed chemotherapy-induced nausea and vomiting. Its review of preclinical and comparative clinical evidence supports palonosetron as an effective component of antiemetic regimens, while also emphasizing that pharmacologic differences must be judged against clinical outcomes and tolerability.

• PFHxS Disrupts Lipid Homeostasis via PPARα

  2026-08-19

  A 2024 Environmental Science & Technology study integrated zebrafish lipidomics, transcriptomics, computational modeling, and antagonist coexposure to examine PFHxS toxicity at environmentally relevant concentrations. The findings identify PPARα activation as a plausible molecular initiating event linking PFHxS exposure with broad lipid remodeling, while also illustrating how integrated omics can strengthen mechanistic inference in aquatic toxicology.

• Full-Length αvβ3 Integrin Conformations by Cryo-EM

  2026-08-19

  This cryo-EM study resolves a broad conformational landscape of full-length human αvβ3 integrin, including previously uncharacterized apo intermediates and distinct ligand-bound states. The findings clarify how integrin activation and inhibitor recognition may be structurally diverse, while providing practical guidance for analyzing intact membrane receptors.

• Cannabidiol, Orofacial Pain, and Affective Recovery

  2026-08-18

  A 2026 Brain Research Bulletin study shows that cannabidiol (CBD) can reduce acute orofacial inflammatory pain while also improving pain-associated affective and cognitive deficits in mice. By combining behavioral assays, molecular profiling, and fiber photometry, the study connects peripheral FAAH–endocannabinoid mechanisms with central CB1 signaling and serotonin dynamics.

• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-08-18

  Oh et al. establish a scalable human iPSC-derived sensory neuron system that supports experimentally defined HSV-1 latency and stimulus-induced reactivation. The model combines neuronal functional validation with virological, transcriptional, and chromatin-based criteria, providing a human-relevant platform for studying latency mechanisms and testing interventions.

• HPF for hROS Detection in Cell Assays

  2026-08-17

  HPF converts selective hROS chemistry into a practical green-fluorescence readout for live-cell microscopy, plate assays, and flow cytometry. This workflow shows how hydroxyphenyl fluorescein can dissect copper-mediated nanotherapy while avoiding the common mistake of treating one ROS signal as proof of an entire cell-death mechanism.

• Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO)

  2026-08-17

  Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) helps limit proteolytic degradation during protein extraction and protease-sensitive assays. Its EDTA-free formulation is suitable for workflows sensitive to divalent cations, but it should not replace EDTA or phosphatase inhibitors when those reagents are specifically required.

• Vincristine Sulfate: Mechanism and Research Use

  2026-08-16

  Vincristine sulfate is a vincristine-containing alkaloid that disrupts microtubule dynamics by inhibiting tubulin polymerization. Its documented activity in cancer research includes B16 melanoma assays and rhabdomyosarcoma xenografts, while product-specific solubility and storage information supports reproducible experimental planning.

• Electrostatic Partitioning in α-Synuclein Condensates

  2026-08-15

  The reference study shows that α-synuclein condensates have a strongly negative electrostatic potential that controls how labeled proteins, fluorophores, and small molecules partition into them. By combining charge-tuned probes, zeta-potential measurements, and a differentiated SH-SY5Y cell model, the work provides a practical framework for studying condensate organization in vitro and inside cells.

• Pravastatin sodium: Assay Workflows

  2026-08-14

  Pravastatin sodium is a selective HMG-CoA reductase inhibitor for probing cholesterol biosynthesis, macrophage lipid handling, and LDL-related phenotypes. This guide translates its biochemical potency into practical cell-based workflows while adding transporter-aware controls for hepatocyte and botanical-interaction studies.

• WRN–MMR Synthetic Lethality in Colon Cancer

  2026-08-14

  The reference study identifies a p53/PUMA-mediated apoptotic mechanism underlying the selective dependence of microsatellite instability colorectal cancer cells on Werner helicase. Its genetic, isogenic, and xenograft experiments support WRN as a therapeutic vulnerability in p53-wild-type MSI tumors while clarifying important limits for pharmacological translation.

• Immune Rejuvenation in Alzheimer’s Disease Mice

  2026-08-13

  Sun and colleagues tested whether replacing aged hematopoietic immune cells with young bone marrow could reduce Alzheimer’s disease-like pathology in aged APP/PS1 mice. Young bone marrow transplantation reshaped peripheral immune-cell gene expression, reduced inflammatory and senescence-associated signals, enhanced peripheral monocyte-associated Aβ clearance, and improved pathological and behavioral outcomes.

8363 records 3/558 page Previous Next 12345 下5页 Last page